averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU2F2
|
ENSG00000028277.16 | POU class 2 homeobox 2 |
POU3F1
|
ENSG00000185668.5 | POU class 3 homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU2F2 | hg19_v2_chr19_-_42636543_42636607 | 0.50 | 3.6e-15 | Click! |
POU3F1 | hg19_v2_chr1_-_38512450_38512474 | 0.31 | 2.8e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_33605231 | 85.76 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
chr14_-_106573756 | 75.03 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr14_-_106994333 | 74.28 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr2_-_89399845 | 71.07 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr14_-_107114267 | 68.34 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr14_-_106692191 | 68.04 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr14_-_106926724 | 67.27 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
chr16_+_32077386 | 66.96 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr2_+_90248739 | 64.54 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr14_-_106552755 | 59.97 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr2_-_89340242 | 52.91 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr16_+_33020496 | 52.82 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr21_+_10862622 | 52.58 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr2_+_90121477 | 51.49 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr14_-_106845789 | 50.27 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr15_-_20193370 | 47.45 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr1_+_149822620 | 47.13 |
ENST00000369159.2
|
HIST2H2AA4
|
histone cluster 2, H2aa4 |
chr16_-_33647696 | 45.84 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
chr1_-_149814478 | 42.85 |
ENST00000369161.3
|
HIST2H2AA3
|
histone cluster 2, H2aa3 |
chr2_-_89459813 | 38.95 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr2_+_90060377 | 38.65 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr2_+_90108504 | 37.72 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_+_90139056 | 37.71 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr14_-_107078851 | 37.49 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr14_-_106610852 | 34.66 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr2_+_90192768 | 34.12 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr16_+_33006369 | 33.52 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
chr6_+_27114861 | 32.82 |
ENST00000377459.1
|
HIST1H2AH
|
histone cluster 1, H2ah |
chr22_+_22930626 | 32.82 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr2_-_89266286 | 32.27 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr2_-_89619904 | 32.21 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr15_-_20170354 | 31.83 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
chr14_-_106518922 | 31.81 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr2_+_90198535 | 31.20 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr1_-_149858227 | 30.68 |
ENST00000369155.2
|
HIST2H2BE
|
histone cluster 2, H2be |
chr2_-_89247338 | 30.65 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr2_+_89952792 | 30.46 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr2_+_90273679 | 30.34 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr22_+_23040274 | 29.87 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr6_+_26124373 | 29.58 |
ENST00000377791.2
ENST00000602637.1 |
HIST1H2AC
|
histone cluster 1, H2ac |
chr22_+_23165153 | 29.41 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr16_+_23847339 | 29.23 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr22_+_23077065 | 28.94 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr14_-_106622419 | 27.86 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
chr16_+_32063311 | 27.03 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
chr2_-_89417335 | 26.68 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr2_+_90211643 | 26.63 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr14_-_107049312 | 26.60 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr2_-_89545079 | 26.36 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr22_+_23046750 | 26.20 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
chr2_-_89568263 | 26.12 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr16_+_33629600 | 25.96 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
chr2_-_89327228 | 25.55 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr1_+_149858461 | 25.51 |
ENST00000331380.2
|
HIST2H2AC
|
histone cluster 2, H2ac |
chr14_-_106816253 | 25.18 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr2_+_89923550 | 25.13 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr4_-_71532339 | 25.00 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr14_-_106539557 | 24.63 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr6_+_37137939 | 24.49 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr2_+_89901292 | 24.42 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr8_+_56792355 | 23.66 |
ENST00000519728.1
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr2_+_114163945 | 23.10 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr14_-_106586656 | 22.43 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr14_-_107283278 | 22.19 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr22_+_23089870 | 22.08 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr14_-_106866934 | 22.04 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
chrX_-_106960285 | 21.81 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr14_-_107170409 | 21.59 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr22_+_22712087 | 20.90 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr8_+_56792377 | 20.71 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr14_-_106725723 | 20.34 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr2_+_90259593 | 19.70 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr14_-_107013465 | 19.34 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr16_+_23847267 | 18.96 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr14_-_107131560 | 18.65 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr22_+_22735135 | 18.54 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr8_-_134115118 | 18.19 |
ENST00000395352.3
ENST00000338087.5 |
SLA
|
Src-like-adaptor |
chr2_+_89975669 | 17.75 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr17_-_47841485 | 17.19 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chr2_+_89998789 | 16.89 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr1_-_149783914 | 16.07 |
ENST00000369167.1
ENST00000427880.2 ENST00000545683.1 |
HIST2H2BF
|
histone cluster 2, H2bf |
chr11_-_5248294 | 15.87 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr6_-_27114577 | 15.07 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
chr18_-_53089723 | 14.99 |
ENST00000561992.1
ENST00000562512.2 |
TCF4
|
transcription factor 4 |
chr17_+_20059302 | 14.42 |
ENST00000395530.2
|
SPECC1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr18_-_52989217 | 14.37 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr22_+_23161491 | 14.28 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
chr2_-_89597542 | 14.11 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr22_+_23154239 | 13.84 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr14_-_107219365 | 12.95 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr14_-_106791536 | 12.52 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr22_+_22764088 | 12.52 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr1_+_156119798 | 11.94 |
ENST00000355014.2
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr10_-_98031265 | 11.39 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr18_-_52989525 | 11.29 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr6_-_27782548 | 11.28 |
ENST00000333151.3
|
HIST1H2AJ
|
histone cluster 1, H2aj |
chrX_+_12993202 | 11.15 |
ENST00000451311.2
ENST00000380636.1 |
TMSB4X
|
thymosin beta 4, X-linked |
chr19_-_17516449 | 10.97 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr10_-_98031310 | 10.91 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chr22_+_23063100 | 10.25 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr19_-_18392422 | 10.08 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
chr7_-_100183742 | 9.87 |
ENST00000310300.6
|
LRCH4
|
leucine-rich repeats and calponin homology (CH) domain containing 4 |
chr6_+_6588902 | 9.64 |
ENST00000230568.4
|
LY86
|
lymphocyte antigen 86 |
chr6_-_26216872 | 9.51 |
ENST00000244601.3
|
HIST1H2BG
|
histone cluster 1, H2bg |
chr1_+_117297007 | 9.39 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
chr4_-_25865159 | 9.18 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr11_-_129872712 | 9.06 |
ENST00000358825.5
ENST00000360871.3 ENST00000528746.1 |
PRDM10
|
PR domain containing 10 |
chr19_+_1269324 | 8.75 |
ENST00000589710.1
ENST00000588230.1 ENST00000413636.2 ENST00000586472.1 ENST00000589686.1 ENST00000444172.2 ENST00000587323.1 ENST00000320936.5 ENST00000587896.1 ENST00000589235.1 ENST00000591659.1 |
CIRBP
|
cold inducible RNA binding protein |
chr22_+_23029188 | 8.60 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr22_-_24096562 | 8.49 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr6_+_27775899 | 8.39 |
ENST00000358739.3
|
HIST1H2AI
|
histone cluster 1, H2ai |
chr2_+_90458201 | 8.36 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
chrX_-_48776292 | 8.29 |
ENST00000376509.4
|
PIM2
|
pim-2 oncogene |
chr2_+_68962014 | 8.25 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr19_+_19144384 | 7.90 |
ENST00000392335.2
ENST00000535612.1 ENST00000537263.1 ENST00000540707.1 ENST00000541725.1 ENST00000269932.6 ENST00000546344.1 ENST00000540792.1 ENST00000536098.1 ENST00000541898.1 ENST00000543877.1 |
ARMC6
|
armadillo repeat containing 6 |
chr6_+_27782788 | 7.82 |
ENST00000359465.4
|
HIST1H2BM
|
histone cluster 1, H2bm |
chr21_+_39644395 | 7.82 |
ENST00000398934.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr12_-_7245125 | 7.79 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr21_+_39644305 | 7.73 |
ENST00000398930.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr6_-_27775694 | 7.72 |
ENST00000377401.2
|
HIST1H2BL
|
histone cluster 1, H2bl |
chr17_-_19651654 | 7.42 |
ENST00000395555.3
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr7_+_26438187 | 7.42 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
chr6_-_34113856 | 7.38 |
ENST00000538487.2
|
GRM4
|
glutamate receptor, metabotropic 4 |
chr11_-_2906979 | 7.16 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr6_+_26158343 | 7.10 |
ENST00000377777.4
ENST00000289316.2 |
HIST1H2BD
|
histone cluster 1, H2bd |
chr7_+_16793160 | 6.93 |
ENST00000262067.4
|
TSPAN13
|
tetraspanin 13 |
chr6_-_27100529 | 6.46 |
ENST00000607124.1
ENST00000339812.2 ENST00000541790.1 |
HIST1H2BJ
|
histone cluster 1, H2bj |
chr17_+_73521763 | 6.41 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr19_-_1021113 | 6.40 |
ENST00000333175.5
ENST00000356663.3 |
TMEM259
|
transmembrane protein 259 |
chrX_+_12993336 | 6.29 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
chr16_+_56969284 | 6.19 |
ENST00000568358.1
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
chr19_+_55128576 | 6.09 |
ENST00000396331.1
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr19_+_35820064 | 6.07 |
ENST00000341773.6
ENST00000600131.1 ENST00000270311.6 ENST00000595780.1 ENST00000597916.1 ENST00000593867.1 ENST00000600424.1 ENST00000599811.1 ENST00000536635.2 ENST00000085219.5 ENST00000544992.2 ENST00000419549.2 |
CD22
|
CD22 molecule |
chr1_+_66797687 | 5.80 |
ENST00000371045.5
ENST00000531025.1 ENST00000526197.1 |
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr17_-_19651668 | 5.71 |
ENST00000494157.2
ENST00000225740.6 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr9_-_127533582 | 5.70 |
ENST00000416460.2
|
NR6A1
|
nuclear receptor subfamily 6, group A, member 1 |
chr4_+_124320665 | 5.70 |
ENST00000394339.2
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr22_-_24096630 | 5.69 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr6_-_82462425 | 5.48 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr6_-_53013620 | 5.36 |
ENST00000259803.7
|
GCM1
|
glial cells missing homolog 1 (Drosophila) |
chr18_-_53253112 | 5.26 |
ENST00000568673.1
ENST00000562847.1 ENST00000568147.1 |
TCF4
|
transcription factor 4 |
chr7_+_100183927 | 4.90 |
ENST00000241071.6
ENST00000360609.2 |
FBXO24
|
F-box protein 24 |
chr1_+_152975488 | 4.89 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
chr4_-_40517984 | 4.86 |
ENST00000381795.6
|
RBM47
|
RNA binding motif protein 47 |
chr6_+_27833034 | 4.73 |
ENST00000357320.2
|
HIST1H2AL
|
histone cluster 1, H2al |
chr12_+_62654119 | 4.68 |
ENST00000353364.3
ENST00000549523.1 ENST00000280377.5 |
USP15
|
ubiquitin specific peptidase 15 |
chr7_-_130080818 | 4.66 |
ENST00000343969.5
ENST00000541543.1 ENST00000489512.1 |
CEP41
|
centrosomal protein 41kDa |
chr11_-_62369291 | 4.59 |
ENST00000278823.2
|
MTA2
|
metastasis associated 1 family, member 2 |
chr1_+_104198377 | 4.54 |
ENST00000370083.4
|
AMY1A
|
amylase, alpha 1A (salivary) |
chr2_-_175462934 | 4.49 |
ENST00000392546.2
ENST00000436221.1 |
WIPF1
|
WAS/WASL interacting protein family, member 1 |
chr11_-_118305921 | 4.47 |
ENST00000532619.1
|
RP11-770J1.4
|
RP11-770J1.4 |
chr11_-_62359027 | 4.39 |
ENST00000494385.1
ENST00000308436.7 |
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific |
chr9_-_84303269 | 4.27 |
ENST00000418319.1
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
chr12_+_62654155 | 4.25 |
ENST00000312635.6
ENST00000393654.3 ENST00000549237.1 |
USP15
|
ubiquitin specific peptidase 15 |
chr7_-_73038822 | 4.25 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
chr6_-_52628271 | 4.24 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
chr7_-_73038867 | 4.23 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
chr11_+_74699703 | 4.17 |
ENST00000529024.1
ENST00000544263.1 |
NEU3
|
sialidase 3 (membrane sialidase) |
chr9_+_136325089 | 4.14 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
chr17_+_43213004 | 4.13 |
ENST00000586346.1
ENST00000398322.3 ENST00000592162.1 ENST00000376955.4 ENST00000321854.8 |
ACBD4
|
acyl-CoA binding domain containing 4 |
chr17_+_38497640 | 4.11 |
ENST00000394086.3
|
RARA
|
retinoic acid receptor, alpha |
chrX_-_130037198 | 3.98 |
ENST00000370935.1
ENST00000338144.3 ENST00000394363.1 |
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2 |
chr6_+_27861190 | 3.94 |
ENST00000303806.4
|
HIST1H2BO
|
histone cluster 1, H2bo |
chr17_-_73127778 | 3.94 |
ENST00000578407.1
|
NT5C
|
5', 3'-nucleotidase, cytosolic |
chr1_+_207669495 | 3.87 |
ENST00000367052.1
ENST00000367051.1 ENST00000367053.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
chr6_+_26273144 | 3.87 |
ENST00000377733.2
|
HIST1H2BI
|
histone cluster 1, H2bi |
chr6_-_52668605 | 3.83 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
chr6_+_27100811 | 3.82 |
ENST00000359193.2
|
HIST1H2AG
|
histone cluster 1, H2ag |
chr22_-_43010928 | 3.64 |
ENST00000348657.2
ENST00000252115.5 |
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3 |
chr8_+_19796381 | 3.62 |
ENST00000524029.1
ENST00000522701.1 ENST00000311322.8 |
LPL
|
lipoprotein lipase |
chr10_-_115904361 | 3.53 |
ENST00000428953.1
ENST00000543782.1 |
C10orf118
|
chromosome 10 open reading frame 118 |
chr6_-_35656712 | 3.47 |
ENST00000357266.4
ENST00000542713.1 |
FKBP5
|
FK506 binding protein 5 |
chr15_-_45406385 | 3.44 |
ENST00000389039.6
|
DUOX2
|
dual oxidase 2 |
chr6_-_11232891 | 3.44 |
ENST00000379433.5
ENST00000379446.5 |
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9 |
chr19_-_50169064 | 3.42 |
ENST00000593337.1
ENST00000598808.1 ENST00000600453.1 ENST00000593818.1 ENST00000597198.1 ENST00000601809.1 ENST00000377139.3 |
IRF3
|
interferon regulatory factor 3 |
chr19_-_40791302 | 3.40 |
ENST00000392038.2
ENST00000578123.1 |
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
chr11_-_75917569 | 3.39 |
ENST00000322563.3
|
WNT11
|
wingless-type MMTV integration site family, member 11 |
chr19_+_35862192 | 3.39 |
ENST00000597214.1
|
GPR42
|
G protein-coupled receptor 42 (gene/pseudogene) |
chr18_-_45457478 | 3.37 |
ENST00000402690.2
ENST00000356825.4 |
SMAD2
|
SMAD family member 2 |
chr14_+_22293618 | 3.36 |
ENST00000390432.2
|
TRAV10
|
T cell receptor alpha variable 10 |
chr2_+_241938255 | 3.35 |
ENST00000401884.1
ENST00000405547.3 ENST00000310397.8 ENST00000342631.6 |
SNED1
|
sushi, nidogen and EGF-like domains 1 |
chr8_-_57123815 | 3.34 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr9_+_92219919 | 3.30 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr5_-_64777733 | 3.28 |
ENST00000381055.3
|
ADAMTS6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
chr12_+_72080253 | 3.23 |
ENST00000549735.1
|
TMEM19
|
transmembrane protein 19 |
chr19_+_35861831 | 3.13 |
ENST00000454971.1
|
GPR42
|
G protein-coupled receptor 42 (gene/pseudogene) |
chr6_+_26217159 | 3.10 |
ENST00000303910.2
|
HIST1H2AE
|
histone cluster 1, H2ae |
chr7_+_50348268 | 3.09 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr19_-_50168962 | 3.06 |
ENST00000599223.1
ENST00000593922.1 ENST00000600022.1 ENST00000596765.1 ENST00000599144.1 ENST00000596822.1 ENST00000598108.1 ENST00000601373.1 ENST00000595034.1 ENST00000601291.1 |
IRF3
|
interferon regulatory factor 3 |
chr22_+_22550113 | 3.01 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr19_+_17337406 | 2.97 |
ENST00000597836.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr15_-_58357932 | 2.97 |
ENST00000347587.3
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
chr17_-_7307358 | 2.92 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr3_+_186435065 | 2.85 |
ENST00000287611.2
ENST00000265023.4 |
KNG1
|
kininogen 1 |
chr4_+_94750014 | 2.80 |
ENST00000306011.3
|
ATOH1
|
atonal homolog 1 (Drosophila) |
chr12_+_81110684 | 2.70 |
ENST00000228644.3
|
MYF5
|
myogenic factor 5 |
chr19_-_3971050 | 2.63 |
ENST00000545797.2
ENST00000596311.1 |
DAPK3
|
death-associated protein kinase 3 |
chr19_-_47164386 | 2.59 |
ENST00000391916.2
ENST00000410105.2 |
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr12_-_99038732 | 2.58 |
ENST00000393042.3
ENST00000420861.1 ENST00000299157.4 ENST00000342502.2 |
IKBIP
|
IKBKB interacting protein |
chr15_-_58357866 | 2.57 |
ENST00000537372.1
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 48.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
14.8 | 44.4 | GO:0070666 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
11.7 | 1750.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
4.0 | 15.9 | GO:0030185 | nitric oxide transport(GO:0030185) |
3.7 | 11.0 | GO:1901253 | negative regulation of dendritic cell cytokine production(GO:0002731) negative regulation of intracellular transport of viral material(GO:1901253) |
3.3 | 565.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
2.7 | 21.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.5 | 17.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.2 | 8.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
2.2 | 24.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
1.9 | 5.7 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.9 | 34.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.9 | 9.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.8 | 5.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.5 | 6.1 | GO:2001193 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
1.4 | 5.6 | GO:0042335 | cuticle development(GO:0042335) |
1.4 | 127.5 | GO:0006342 | chromatin silencing(GO:0006342) |
1.3 | 8.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.1 | 3.4 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
1.1 | 3.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.0 | 4.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.0 | 4.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.0 | 4.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.8 | 2.5 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.8 | 0.8 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.8 | 4.0 | GO:0048511 | rhythmic process(GO:0048511) |
0.8 | 7.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.8 | 4.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.7 | 6.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.7 | 2.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.7 | 8.5 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.7 | 2.1 | GO:0003099 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.7 | 2.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) positive regulation of sarcomere organization(GO:0060298) |
0.6 | 2.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.6 | 5.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 1.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.6 | 3.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.5 | 9.9 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.5 | 12.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.5 | 2.6 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.5 | 3.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.5 | 2.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.5 | 2.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 8.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 2.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.5 | 1.5 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.5 | 2.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 7.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 5.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.5 | 1.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.5 | 2.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 11.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 8.0 | GO:0046135 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) pyrimidine nucleoside catabolic process(GO:0046135) |
0.4 | 4.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 0.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 2.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.3 | 15.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 2.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 0.9 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.3 | 4.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 1.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 5.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 2.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 2.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 3.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 2.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 3.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 1.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 1.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 18.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 49.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.2 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 6.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 3.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 4.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 1.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 2.6 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 23.6 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 8.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 6.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 1.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.4 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.1 | 10.0 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 2.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 4.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 2.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 5.6 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.1 | 0.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 1.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 2.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 2.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 1.1 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 5.5 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 3.3 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 6.9 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
0.1 | 1.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 3.8 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 2.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 3.3 | GO:0003279 | cardiac septum development(GO:0003279) |
0.0 | 1.0 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 1.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 4.2 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 4.8 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 2.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 1.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 1.0 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 5.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.4 | GO:0007507 | heart development(GO:0007507) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.0 | 801.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
8.9 | 44.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
4.0 | 15.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.5 | 198.1 | GO:0000786 | nucleosome(GO:0000786) |
1.8 | 315.7 | GO:0072562 | blood microparticle(GO:0072562) |
1.3 | 10.1 | GO:0035976 | AP1 complex(GO:0035976) |
1.0 | 6.2 | GO:1990037 | Lewy body core(GO:1990037) |
1.0 | 4.1 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 3.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 2.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 17.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.4 | 2.4 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.4 | 621.9 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 9.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 1.5 | GO:1990031 | pinceau fiber(GO:1990031) |
0.4 | 4.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 41.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 3.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 3.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 5.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 11.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 4.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 6.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 8.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 7.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 2.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 14.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 9.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 288.3 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 3.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 2.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 2.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 1.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 1.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.0 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 48.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
14.6 | 801.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
7.4 | 1385.5 | GO:0003823 | antigen binding(GO:0003823) |
6.2 | 43.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.5 | 45.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
2.6 | 15.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.6 | 7.8 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
2.4 | 21.8 | GO:0043426 | MRF binding(GO:0043426) |
2.0 | 6.1 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
1.7 | 24.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.5 | 6.0 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.5 | 8.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.3 | 18.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.2 | 3.6 | GO:0017129 | triglyceride binding(GO:0017129) |
1.2 | 22.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.1 | 4.5 | GO:0016160 | amylase activity(GO:0016160) |
1.1 | 4.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.1 | 8.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.0 | 10.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 15.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 2.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 9.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 4.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.4 | 11.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 12.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 7.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 5.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 2.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 2.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.3 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 2.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 3.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 4.5 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 2.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 4.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.2 | 18.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 6.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 5.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 120.7 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.2 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 4.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 4.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 3.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 4.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 4.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 5.7 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 5.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 2.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 1.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 2.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 2.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 7.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.8 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 70.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.2 | 47.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 22.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 15.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 39.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 3.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 10.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 5.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 6.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 9.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 3.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 2.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 210.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
2.6 | 44.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.5 | 43.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.9 | 48.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 8.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 22.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 11.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 7.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 15.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 4.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 7.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 3.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 5.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 7.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 5.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 8.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 13.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 4.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 6.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 17.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 5.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 4.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 10.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 3.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 6.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 6.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 6.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 6.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 1.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |